BMS, Nvidia push to build life sciences’ most powerful AI engine
TL;DR Summary
Bristol Myers Squibb is expanding its Nvidia-powered infrastructure with the DGX SuperPOD to create what it calls the most powerful, energy-efficient AI platform in life sciences, enabling hybrid human-AI science to accelerate R&D and improve decision quality across its pipeline; the move extends a multi-year collaboration with Nvidia and aligns with other pharma AI partnerships in the sector.
- BMS, Nvidia aim for ‘most powerful AI factory in life sciences’ Fierce Biotech
- Bristol Myers buys Nvidia's latest AI computing system for drug research Yahoo Finance
- Bristol Myers Squibb Building Life Science Industry’s Most Advanced AI Factory on NVIDIA Vera Rubin NVIDIA Blog
- Bristol Myers Squibb becomes latest company to claim it’s building pharma’s largest NVIDIA AI supercomputer STAT
- Bristol Partners With Nvidia on AI Factory for Drug Development Bloomberg.com
Reading Insights
Total Reads
0
Unique Readers
10
Time Saved
1 min
vs 2 min read
Condensed
83%
337 → 58 words
Want the full story? Read the original article
Read on Fierce Biotech